Gerard M. Housey, M.D., Ph.D.
Dr. Housey is the President and CEO of Housey Pharmaceutical Research Laboratories, and directs the company’s research and development programs. Dr. Housey is the inventor of target-specific cell-based assay systems, a core, enabling technology that is currently in widespread use within the pharmaceutical industry.
Dr. Housey received his undergraduate degree from the University of Michigan, and his Ph.D. in Human Genetics (1988) and M.D. (1991) from Columbia University’s College of Physicians and Surgeons in New York City. He is a licensed physician in New York and Michigan. During his graduate studies he filed his first patent applications in the area of cell-based assay technology and founded Progenics Pharmaceuticals, Inc., (Nasdaq: PGNX) in 1986. He served as president of that company from inception until 1990. From 1991 to 1993 he was a resident physician in Clinical Pathology and Laboratory Medicine in the Department of Pathology at Columbia University’s Presbyterian Hospital in New York. From 1994-1995 he conducted cancer research as a basic science fellow at the National Cancer Institute (National Institutes of Health) in Frederick, Maryland.